BONINE Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

BONINE General Information

Description

Provider of over-the-counter drug intended for motion sickness. The company offers antiemetics, chewable tablets and other non-medication treatments, thereby enabling its consumers to be provided with reliable drugs to overcome motion sickness.

Contact Information

Website
www.bonine.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Primary Industry
Drug Delivery
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Parent Company
Primary Office
  • 660 White Plains Road
  • Suite 250
  • Tarrytown, NY 10591
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BONINE Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BONINE‘s full profile, request access.

Request a free trial

BONINE Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore BONINE‘s full profile, request access.

Request a free trial